Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What is the anticipated market size of the intravascular catheterization industry over the next few years?
The intravascular catheterization market size has grown strongly in recent years. It will grow from $12.72 billion in 2024 to $13.64 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increasing cardiovascular disease cases, rising hospital admission rates, a growing geriatric patient population, increasing minimally invasive procedures, and growing chronic disease prevalence.
The intravascular catheterization market size is expected to see strong growth in the next few years. It will grow to $17.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rising outpatient care facilities, increasing catheterization laboratory numbers, growing demand for advanced catheters, increasing regulatory approvals granted, and rising awareness of catheterization techniques. Major trends in the forecast period include advancements in antimicrobial catheter coatings, integration of AI for real-time imaging guidance, technology enabling smart catheters with sensors, developments in ultrasound-assisted catheter placement, and advancements in biocompatible catheter materials.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24264&type=smp
What emerging drivers are expected to shape the future of the intravascular catheterization market?
The increasing incidence of cardiovascular disorders is expected to propel the growth of the intravascular catheterization market going forward. Cardiovascular disorders refer to a range of conditions that affect the heart and blood vessels, such as heart disease, stroke, and high blood pressure. The increasing incidence of cardiovascular disorders is largely due to the rising rates of obesity, which contribute to risk factors such as high blood pressure and diabetes, both of which increase the likelihood of heart disease. Intravascular catheterization is useful for cardiovascular disorders as it allows for minimally invasive procedures to diagnose and treat conditions such as coronary artery disease, perform angioplasty, and place stents to improve blood flow. For instance, in January 2025, according to the American Heart Association, a US-based nonprofit organization, the total number of cardiovascular disease (CVD)-related deaths in the U.S. reached 941,652 in 2022, marking an increase of over 10,000 compared to the 931,578 CVD deaths reported in 2021. Therefore, the increasing incidence of cardiovascular disorders is driving the growth of the intravascular catheterization market.
What emerging segments are shaping the future landscape of the intravascular catheterization industry?
The intravascular catheterization market covered in this report is segmented –
1) By Type: Centrally Inserted Catheters, Peripherally Inserted Central Catheters (PICC), Peripheral Catheters, Dialysis Catheters
2) By Material: Polyurethane, Silicone, Polyvinyl Chloride (Pvc), Other Materials
3) By Procedures: Elective Procedures, Emergency Procedures, Interventional Radiology, Cardiac Procedures
4) By Application: Oncology, Cardiology, Pediatrics, Infection Control
5) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Home Healthcare, Research Laboratories
Subsegments:
1) By Centrally Inserted Catheters: Non-Tunneled Central Venous Catheters, Tunneled Central Venous Catheters, Implantable Ports
2) By Peripherally Inserted Central Catheters (PICC): Single Lumen PICC, Double Lumen PICC, Triple Lumen PICC
3) By Peripheral Catheters: Short Peripheral Intravenous Catheters, Midline Catheters, Winged Infusion Sets
4) By Dialysis Catheters: Temporary Dialysis Catheters, Tunneled Dialysis Catheters, Non-Tunneled Dialysis Catheters
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/intravascular-catheterization-global-market-report
What are the top market trends driving innovation in the intravascular catheterization industry?
Major companies operating in the intravascular catheterization market are focusing on developing technologically advanced solutions, such as artificial intelligence (AI)-powered intravascular ultrasound (IVUS) systems, to enhance imaging precision and streamline clinical workflows. AI-powered intravascular ultrasound (IVUS) systems refer to advanced medical imaging devices that combine traditional intravascular ultrasound (IVUS) technology with artificial intelligence (AI) algorithms to improve the accuracy, efficiency, and interpretability of imaging during cardiovascular procedures. For instance, in October 2023, Evident Vascular Inc., a US-based medical technology company, launched an AI-enabled intravascular ultrasound (IVUS) platform designed to capture high-precision images from inside blood vessels, primarily to assess vascular disease and guide interventional treatments. This next-generation, catheter-based ultrasound technology leverages artificial intelligence to enhance image quality, improve interpretation, and streamline workflow for clinicians, with an initial focus on peripheral vascular interventions and plans to expand into coronary applications.
How are key players in the intravascular catheterization market strengthening their market position?
Major companies operating in the intravascular catheterization market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Teleflex Incorporated, Cook Medical LLC, ICU Medical Inc., Smiths Medical, Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., ACIST Medical Systems Inc., C. R. Bard Inc., Shanghai Kindly Enterprise Development Group Co. Ltd.
Which geographic areas are contributing significantly to the growth of the intravascular catheterization sector?
North America was the largest region in the intravascular catheterization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravascular catheterization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Intravascular Catheterization Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24264&type=smp
Need Customized Data On Intravascular Catheterization Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24264&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
